IKNA — Ikena Oncology Balance Sheet
0.000.00%
- $69.54m
- -$87.81m
- $9.16m
- 24
- 29
- 22
- 14
Annual balance sheet for Ikena Oncology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 82.1 | 162 | 232 | 157 | 175 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 85.2 | 166 | 237 | 160 | 179 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.769 | 1.56 | 8.98 | 8.46 | 8.02 |
Other Long Term Assets | |||||
Total Assets | 86 | 168 | 248 | 172 | 192 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 24.3 | 28.3 | 27.2 | 21.5 | 14.2 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 68.6 | 63.5 | 40 | 25.3 | 22.3 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 17.4 | 105 | 208 | 147 | 170 |
Total Liabilities & Shareholders' Equity | 86 | 168 | 248 | 172 | 192 |
Total Common Shares Outstanding |